Pharmacological Correction of Cisplatin-Induced Hemostatic Disorders
- 31 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bulletin of Experimental Biology and Medicine
- Vol. 170 (5), 623-626
- https://doi.org/10.1007/s10517-021-05119-1
Abstract
A single intraperitoneal administration of cisplatin in the MTD to outbred female mice disturbed hemostasis and formed the procoagulant phenotype of hemostatic potential on days 7-10 culminating in a pronounced hypocoagulation on day 15. Hemostasis was corrected with warfarin and an extract containing furocoumarins composed of isopimpinellin (42.97%), bergapten (35.18%), and xanthotoxin (15.41%). The extract was standardized with gas chromatography-mass spectrometry, thin-layer chromatography, and HPLC. Furocoumarins and reference drug warfarin were administered intragastrically during 4 days starting on day 6 after the administration of cisplatin. Both furocoumarins and warfarin corrected hypercoagulation on days 7-10. On day 10, furocoumarins normalized coagulation, whereas warfarin resulted in hypocoagulation. On days 15-30, no effects of warfarin were observed. furocoumarins corrected hypocoagulation on days 15-20 with prolongation of this effect up to experimental day 30.Keywords
This publication has 14 references indexed in Scilit:
- The Effect of Furanocoumarin Derivatives on Induction of Apoptosis and Multidrug Resistance in Human Leukemic CellsMolecules, 2019
- Bergapten Ameliorates Vincristine-Induced Peripheral Neuropathy by Inhibition of Inflammatory Cytokines and NFκB SignalingACS Chemical Neuroscience, 2019
- Bergapten induces G1 arrest of non‑small cell lung cancer cells, associated with the p53‑mediated cascadeMolecular Medicine Reports, 2019
- Antitumor and apoptotic effects of 5-methoxypsoralen in U87MG human glioma cells and its effect on cell cycle, autophagy and PI3K/Akt signaling pathwayVideosurgery and Other Miniinvasive Techniques, 2019
- Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibitionBlood, 2018
- α-Glucosidase inhibitory and antioxidant activity of furanocoumarins from Heracleum persicumMedicinal Chemistry Research, 2017
- Imperatorin acts as a cisplatin sensitizer via downregulating Mcl-1 expression in HCC chemotherapyTumor Biology, 2015
- Antiplatelet and Anticoagulant Activities ofAngelica shikokianaExtract and Its Isolated CompoundsClinical and Applied Thrombosis/hemostasis, 2015
- Global Tests in Evaluation of the Function of Proand Anticoagulant Systems: Present and FutureBulletin of Experimental Biology and Medicine, 2015
- Risk of Venous Thromboembolism in Patients With Cancer Treated With Cisplatin: A Systematic Review and Meta-AnalysisJournal of Clinical Oncology, 2012